Salvage esophagectomy after definitive chemoradiotherapy for synchronous double cancers of the esophagus and head-and-neck

Diseases of the Esophagus

Volumn 23, Issue 1, 2010, Pages 59-63

  Yoshida, R ^a   Morita, M ^a   Ando, K ^a   Masuda, T ^a   Saeki, H ^a   Oki, E ^a   Sadanaga, N ^a   Nakashima, T ^b   Kakeji, Y ^a   Maehara, Y ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Esophageal cancer; Head and neck cancer; Salvage esophagectomy

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HEAD AND NECK CANCER; HUMAN; LUNG COMPLICATION; MALE; MINIMAL RESIDUAL DISEASE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SALVAGE THERAPY; TREATMENT INDICATION; TREATMENT RESPONSE;

AGED; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; NEOPLASMS, MULTIPLE PRIMARY; RADIOTHERAPY, ADJUVANT; SALVAGE THERAPY;

EID: 77953183749     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2009.00973.x     Document Type: Article

References (27)

1. Abemayor E, Moore D M, Hanson D G. Identification of synchronous esophageal tumors in patients with head and neck cancer. J Surg Oncol 1988; 38: 94-6.
2. Kuwano H, Morita M, Tsutsui S, Kido Y, Mori M, Sugimachi K. Comparison of characteristics of esophageal squamous cell carcinoma associated with head and neck cancer and those with gastric cancer. J Surg Oncol 1991; 46: 107-9.
3. Morita M, Kuwano H, Ohno S et al. Multiple occurrence of carcinoma in the upper aerodigestive tract associated with esophageal cancer: reference to smoking, drinking and family history. Int J Cancer 1994; 58: 207-10.
4. Morita M, Kuwano H, Nakashima T et al. Family aggregation of carcinoma of the hypopharynx and cervical esophagus: special reference to multiplicity of cancer in upper aerodigestive tract. Int J Cancer 1998; 76: 468-71.
5. Morita M, Saeki H, Mori M, Kuwano H, Sugimachi K. Risk factors for esophageal cancer and the multiple occurrence of carcinoma in the upper aerodigestive tract. Surgery 2002; 131: S1-6.
6. Morita M, Yoshida R, Ikeda K et al. Advances in esophageal cancer surgery in japan: an analysis of 1000 consecutive patients treated at a single institute. Surgery 2008; 143: 499-508.
7. Al-Sarraf M, Martz K, Herskovic A et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 1997; 15: 277-84.
8. Minsky B D, Pajak T F, Ginsberg R J et al. Int 0123 (radiation therapy oncology group 94-05) phase iii trial of combinedmodality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 2002; 20: 1167-74.
9. Hironaka S, Ohtsu A, Boku N et al. Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with t(2-3)n(any) m(0) squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 2003; 57: 425-33.
10. Oki E, Morita M, Kakeji Y et al. Salvage esophagectomy after definitive chemoradiotherapy for esophageal cancer. Dis Esophagus 2007; 20: 301-4.
11. Swisher S G, Wynn P, Putnam J B et al. Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. J Thorac Cardiovasc Surg 2002; 123: 175-83.
12. Tomimaru Y, Yano M, Takachi K, Miyashiro I, Ishihara R, Nishiyama K. Factors affecting the prognosis of patients with esophageal cancer undergoing salvage surgery after definitive chemoradiotherapy. J Surg Oncol 2006; 93: 422-8.
13. Nakamura T, Hayashi K, Ota M et al. Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal cancer. Am J Surg 2004; 188: 261-6.
14. Heitmiller R F, McQuone S J, Eisele D W. The utility of the pectoralis myocutaneous flap in the management of select cervical esophageal anastomotic complications. J Thorac Cardiovasc Surg 1998; 115: 1250-4.
15. Slaughter D P, Southwick H W, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953; 6: 963-8.
16. Weaver A, Fleming S M, Knechtges T C, Smith D. Triple endoscopy: a neglected essential in head and neck cancer. Surgery 1979; 86: 493-6.
17. Poon R T, Law S Y, Chu KM, Branicki F J, Wong J. Multiple primary cancers in esophageal squamous cell carcinoma: incidence and implications. Ann Thorac Surg 1998; 65: 1529-34.
18. Kumagai Y, Kawano T, Nakajima Y et al. Multiple primary cancers associated with esophageal carcinoma. Surg Today 2001; 31: 872-6.
19. Pfister D G, Harrison L B, Strong E W et al. Organ-function preservation in advanced oropharynx cancer: results with induction chemotherapy and radiation. J Clin Oncol 1995; 13: 671-80.
20. Herskovic A, Martz K, al-Sarraf M et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992; 326: 1593-8.
21. Ohtsu A, Boku N, Muro K et al. Definitive chemoradiotherapy for t4 and/or m1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 1999; 17: 2915-21.
22. Cooper J S, Guo M D, Herskovic A et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (rtog 85-01). Radiation therapy oncology group. JAMA 1999; 281: 1623-7.
23. Chan A, Wong A. Is combined chemotherapy and radiation therapy equally effective as surgical resection in localized esophageal carcinoma? Int J Radiat Oncol Biol Phys 1999; 45: 265-70.
24. Yano T, Muto M, Minashi K, Ohtsu A, Yoshida S. Photodynamic therapy as salvage treatment for local failures after definitive chemoradiotherapy for esophageal cancer. Gastrointest Endosc 2005; 62: 31-6.
25. Hattori S, Muto M, Ohtsu A et al. EMR as salvage treatment for patients with locoregional failure of definitive chemoradiotherapy for esophageal cancer. Gastrointest Endosc 2003; 58: 65-70.
26. Urschel J D, Sellke F W. Complications of salvage esophagectomy. Med Sci Monit 2003; 9: RA173-80.
27. Akamoto S, Okano K, Sano T et al. Neutrophil elastase inhibitor (sivelestat) preserves antitumor immunity and reduces the inflammatory mediators associated with major surgery. Surg Today 2007; 37: 359-65.